Human Mutation · 2012 · 20 citations · 40 references
Life SciencesGeneticsMolecular GeneticsCancer GeneticsGenomicsMolecular OncologyCancer GenomicsCancer Molecular DiagnosticsDna SequencingGenetic MappingGenome RearrangementMutation AnalysisArray Comparative Genomic HybridizationChromosome RearrangementsGene Rearrangement AnalysisGenomic Rearrangement DetectionGermline Variant DetectionIntrachromosomal RearrangementsPoint MutationsStructural Rearrangement Detection
The BRCA1 and BRCA2 genes are involved in breast and ovarian cancer susceptibility. About 2 to 4% of breast cancer patients with positive family history, negative for point mutations, can be expected to carry large rearrangements in one of these two genes. We developed a novel diagnostic genetic test for the physical mapping of large rearrangements, based on molecular combing (MC), a FISH-based technique for direct visualization of single DNA molecules at high resolution. We designed specific Genomic Morse Codes (GMCs), covering the exons, the noncoding regions, and large genomic portions flanking both genes. We validated our approach by testing 10 index cases with positive family history of breast cancer and 50 negative controls. Large rearrangements, corresponding to deletions and duplications with sizes ranging from 3 to 40 kb, were detected and characterized on both genes, including four novel mutations. The nature of all the identified mutations was confirmed by high-resolution array comparative genomic hybridization (aCGH) and breakpoints characterized by sequencing. The developed GMCs allowed to localize several tandem repeat duplications on both genes. We propose the developed genetic test as a valuable tool to screen large rearrangements in BRCA1 and BRCA2 to be combined in clinical settings with an assay capable of detecting small mutations.
40
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Statistics Notes: Diagnostic tests 1: sensitivity and specificity
Douglas G. Altman, J Martin Bland · BMJ · 1994 · 2.1K citations · Full text
Spectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast Cancer
Tom Walsh, Silvia Casadei, Kathryn Hale Coats et al. · JAMA · 2006 · 666 citations